Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference. - Wikidata - awgldk - TriplyDB

Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference.

Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference.

http://www.wikidata.org/entity/Q34526756

about

Animal models for Ebola and Marburg virus infections Viral hemorrhagic fevers: advancing the level of treatment The 2014–2015 Ebola outbreak in West Africa: Hands On Emerging targets and novel approaches to Ebola virus prophylaxis and treatment Ebola haemorrhagic fever Monitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in Liberia siRNA Versus miRNA as Therapeutics for Gene Silencing Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives Mouse models for filovirus infections Development of RNA Aptamers Targeting Ebola Virus VP35 Progress toward in vivo use of siRNAs-II Neglected filoviruses Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us Progress towards the treatment of Ebola haemorrhagic fever.Updates in diagnosis and management of Ebola hemorrhagic fever.Pertussis: Microbiology, Disease, Treatment, and Prevention.The Ebola virus VP35 protein is a suppressor of RNA silencing.Development and characterization of a mouse model for Marburg hemorrhagic fever Intracranial administration of P gene siRNA protects mice from lethal Chandipura virus encephalitis.Advances in Systemic siRNA Delivery Attenuated Salmonella choleraesuis-mediated RNAi targeted to conserved regions against foot-and-mouth disease virus in guinea pigs and swine Drug delivery-mediated control of RNA immunostimulation Synthesis of lipid-oligonucleotide conjugates for RNA interference studies.Are we any closer to combating Ebola infections?Filovirus replication and transcription.Treatment of ebola virus disease.Enzymatically produced pools of canonical and Dicer-substrate siRNA molecules display comparable gene silencing and antiviral activities against herpes simplex virus.Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates Structures of protective antibodies reveal sites of vulnerability on Ebola virus.Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach.Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies.Administration of E2 and NS1 siRNAs inhibit chikungunya virus replication in vitro and protects mice infected with the virus.Evaluation of the potential impact of Ebola virus genomic drift on the efficacy of sequence-based candidate therapeutics.Lentviral-mediated RNAi to inhibit target gene expression of the porcine integrin αv subunit, the FMDV receptor, and against FMDV infection in PK-15 cells.Harnessing RNAi nanomedicine for precision therapy Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting Postexposure treatment of Marburg virus infection The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States Potential vaccines and post-exposure treatments for filovirus infections.A Syrian golden hamster model recapitulating ebola hemorrhagic fever.

P2860

Q21131118-86DCA662-7EB8-46E8-AE76-413F6B10684A Q21245298-9D0F6304-F9CA-4206-9F09-93B1F094C599 Q24049114-B5D2FDDF-F76C-4F5F-82D0-FEAC08EB9D1B Q24597625-06F3F69D-BC5B-41E1-B72C-EE4298585B5C Q24629338-6EC0A54E-A847-4CC3-853D-216F77904C65 Q24696012-6F6BE361-9FF5-4000-9E44-256ABE101D2B Q26786876-ECBA67ED-B478-43E3-9E23-D0EDFB64F35C Q26859021-DE8329E2-8DC0-441C-8F4D-24A322A087FE Q27011569-49D40017-1887-4668-A92A-5CA8039E95DB Q27680060-87E84ADB-40A3-415F-A54F-F3564E8BB9E8 Q28255877-0CFDD6CE-12EE-4C3D-A8CF-B87EDCC996BC Q28383265-36A4D35A-3711-4479-8A9F-29374D72E5B9 Q28397866-3CBDBC74-5729-42C9-BF83-A00D42D39D02 Q30230272-6BA6FB85-F1C7-4605-9FC7-400C8CE56FA7 Q30238537-94432C1C-E2D4-455D-A046-642EC157CEB2 Q30251684-8E812926-8D41-4E82-9BDF-A3996242546B Q33288729-7663E67D-72F2-4D99-BF75-0FCAF62109B7 Q33384111-5A8B903C-179C-4BD4-906E-8FD1845C68D2 Q33523028-ED20EDAD-313E-4C25-B478-990BE31CBB70 Q33613316-C4168A49-0F73-4BE6-B923-FEA89094BDDD Q33676729-7F31FD89-40CE-43E6-8C53-776823C91A87 Q33713938-C5BFDF64-F066-4566-9BC4-EA1F60BE6F67 Q33825496-48DEBFC3-9548-4E30-8B53-04DCA953D056 Q34022601-081D060A-D9D3-488E-AD2F-230CA1FD8188 Q34375243-42DEA774-F2A9-48C0-85A0-E129F8BE68CF Q34460182-1A2FE219-13D4-493D-B597-D05428FF18AC Q34506213-A59FFE9F-D2EC-4C22-98CF-B5EF338F37B1 Q34589949-75A48BB7-B9D9-40DD-BACB-0F0977FB0641 Q34661120-7F9EFDA7-63E7-4760-A778-2B0A7E3E2F40 Q34741896-C54F7A32-170D-48FB-BCC3-76061922C34C Q34971349-3B1C96A4-750D-417C-A903-30EADD159258 Q34990686-0A06B4AB-9331-4119-B217-C447803DFB90 Q35038226-E10B44FC-C10E-4001-8FC9-9DDA13709609 Q35241638-2EDEA6A6-7BF7-439C-B167-D510FD473F87 Q35673875-D43D21E6-D5AD-45D5-96B7-B65905CA3F93 Q35697443-7D425F71-4A9A-4A22-83A2-27659A4034FA Q35877126-884744F9-13EB-4D9D-818B-B06D38C3153F Q35974433-DD07D088-EA15-457C-8AD1-E708A50B60A4 Q36404178-9833422E-B715-424D-87C3-375EDBF16AEE Q36495558-83E87C6F-EF03-4A38-84D2-E3233E5E2532

P2860

Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference.

http://www.wikidata.org/entity/Q34526756

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Postexposure protection of gui ...... conferred by RNA interference.

@ast

Postexposure protection of gui ...... conferred by RNA interference.

@en

Postexposure protection of gui ...... conferred by RNA interference.

@nl

type

label

Postexposure protection of gui ...... conferred by RNA interference.

@ast

Postexposure protection of gui ...... conferred by RNA interference.

@en

Postexposure protection of gui ...... conferred by RNA interference.

@nl

prefLabel

Postexposure protection of gui ...... conferred by RNA interference.

@ast

Postexposure protection of gui ...... conferred by RNA interference.

@en

Postexposure protection of gui ...... conferred by RNA interference.

@nl

P1433

Q34526756-9BE1AF4A-3328-4940-A974-F6475D3DEE6E

P1476

Q34526756-1291F00A-B386-4107-9A19-989064B8C3BA

P2093

Q34526756-1150DFF2-5565-4166-AC7B-6DF99A74D1A2

Q34526756-43D2D1C9-C705-4E43-AB06-A2160F218277

Q34526756-5A6AE588-C4DD-46BC-A158-957453246B4C

Q34526756-78713538-EC27-4A9A-AB4C-BE52EE61771E

Q34526756-7EAD69E0-0E1F-49A6-B6F4-CE25F2AF5CA7

Q34526756-969BAEAF-0E68-462E-B85A-626B3CE3D26D

Q34526756-DCD774DD-10E4-4406-A4C4-8C5388E7F1D1

Q34526756-E7EB674E-9F3C-4F4E-9976-44186DF5AC54

Q34526756-E85AA5E2-ED7B-4A5D-A8C2-F6313D1273E5

Q34526756-F620D907-B73E-451A-B8F0-E8D934E3AC1F

P304

Q34526756-A76C7EC0-C8D4-48B8-986A-7AE9F473CB5C

P31

Q34526756-C346F5C5-1BE7-4BD6-BDE8-45EB0DA83F40

P356

Q34526756-EE9D06DA-82A7-4BF5-A2E5-93A2E1827F2A

P407

Q34526756-8AA3523E-0B77-446A-85B4-627D9FF3DE9C

P433

Q34526756-1771E787-CED3-41B5-ACE6-8AA611C416EC

P478

Q34526756-4C9D57F1-58D7-4A0C-8AAB-473862F21CD8

P50

Q34526756-0C51C65D-4EA3-480E-BA56-8DCB8EEEA5CD

Q34526756-42E55406-4FFD-4CC8-8D0F-72B136AE5BED

Q34526756-587F7A73-B44C-4B1D-BE08-E029DA2D22C4

Q34526756-D413C319-1670-4151-9DF5-A5910BBC4EA1

P577

Q34526756-AAD9FD10-B383-41D4-B2BF-ECF736A341F4

P5875

Q34526756-9A32EC52-98A4-4958-BB0B-CFA3B7DF3231

P698

Q34526756-10094D9D-2F00-42BD-AE50-EA790011BF3C

P921

Q34526756-1A9D8FC9-34B0-4EA2-82E3-0D99854D9B8B

Q34526756-FB9E9874-4BED-445F-99E1-E36FB6EAEF2E

P356

P1433

The Journal of Infectious Diseases

P1476

Postexposure protection of gui ...... conferred by RNA interference.

@en

P2093

Adam Judge

http://www.w3.org/2001/XMLSchema#string

Amy C H Lee

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Fritz

http://www.w3.org/2001/XMLSchema#string

Elliott Kagan

http://www.w3.org/2001/XMLSchema#string

Erik Zhaoying Yu

http://www.w3.org/2001/XMLSchema#string

Ian MacLachlan

http://www.w3.org/2001/XMLSchema#string

Janet R Phelps

http://www.w3.org/2001/XMLSchema#string

Joan B Geisbert

http://www.w3.org/2001/XMLSchema#string

Kevin McClintock

http://www.w3.org/2001/XMLSchema#string

Lloyd B Jeffs

http://www.w3.org/2001/XMLSchema#string

P304

1650-1657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/504267

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

193

http://www.w3.org/2001/XMLSchema#string

P50

Peter B. Jahrling

Thomas W Geisbert

Kathleen M Daddario-DiCaprio

P577

2006-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7077134

http://www.w3.org/2001/XMLSchema#string

P698

16703508

http://www.w3.org/2001/XMLSchema#string

P921

2014 Ebola virus epidemic in Guinea